Osteoporosis, Postmenopausal
"Osteoporosis, Postmenopausal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
Concept/Terms
Osteoporosis, Postmenopausal- Osteoporosis, Postmenopausal
- Perimenopausal Bone Loss
- Osteoporosis, Post-Menopausal
- Osteoporoses, Post-Menopausal
- Osteoporosis, Post Menopausal
- Post-Menopausal Osteoporoses
- Post-Menopausal Osteoporosis
- Postmenopausal Bone Loss
- Postmenopausal Osteoporosis
- Osteoporoses, Postmenopausal
- Postmenopausal Osteoporoses
- Bone Loss, Perimenopausal
- Bone Losses, Perimenopausal
- Perimenopausal Bone Losses
- Bone Loss, Postmenopausal
- Bone Losses, Postmenopausal
- Postmenopausal Bone Losses
Below are MeSH descriptors whose meaning is more general than "Osteoporosis, Postmenopausal".
Below are MeSH descriptors whose meaning is more specific than "Osteoporosis, Postmenopausal".
This graph shows the total number of publications written about "Osteoporosis, Postmenopausal" by people in Harvard Catalyst Profiles by year, and whether "Osteoporosis, Postmenopausal" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 1 | 2 |
| 1992 | 1 | 0 | 1 |
| 1993 | 2 | 0 | 2 |
| 1994 | 0 | 2 | 2 |
| 1995 | 2 | 1 | 3 |
| 1996 | 4 | 4 | 8 |
| 1997 | 2 | 3 | 5 |
| 1998 | 2 | 6 | 8 |
| 1999 | 4 | 1 | 5 |
| 2000 | 8 | 3 | 11 |
| 2001 | 7 | 4 | 11 |
| 2002 | 6 | 1 | 7 |
| 2003 | 11 | 8 | 19 |
| 2004 | 10 | 4 | 14 |
| 2005 | 5 | 5 | 10 |
| 2006 | 4 | 3 | 7 |
| 2007 | 6 | 2 | 8 |
| 2008 | 6 | 5 | 11 |
| 2009 | 8 | 2 | 10 |
| 2010 | 13 | 4 | 17 |
| 2011 | 9 | 6 | 15 |
| 2012 | 5 | 4 | 9 |
| 2013 | 5 | 3 | 8 |
| 2014 | 9 | 3 | 12 |
| 2015 | 5 | 6 | 11 |
| 2016 | 5 | 0 | 5 |
| 2017 | 10 | 4 | 14 |
| 2018 | 3 | 1 | 4 |
| 2019 | 4 | 1 | 5 |
| 2020 | 7 | 0 | 7 |
Below are the most recent publications written about "Osteoporosis, Postmenopausal" by people in Profiles.
-
Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial. Osteoporos Int. 2021 Jan; 32(1):55-61.
-
Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis. Osteoporos Int. 2020 Dec; 31(12):2413-2424.
-
Dietary Approaches to Stop Hypertension, Mediterranean, and Alternative Healthy Eating indices are associated with bone health among Puerto Rican adults from the Boston Puerto Rican Osteoporosis Study. Am J Clin Nutr. 2020 06 01; 111(6):1267-1277.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. Endocr Pract. 2020 May; 26(Suppl 1):1-46.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE EXECUTIVE SUMMARY. Endocr Pract. 2020 May; 26(5):564-570.
-
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT. J Clin Endocrinol Metab. 2020 03 01; 105(3).
-
Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis. J Clin Endocrinol Metab. 2020 03 01; 105(3).
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diabetes Endocrinol. 2019 12; 7(12):899-911.
-
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. Lancet Diabetes Endocrinol. 2019 10; 7(10):767-775.
-
Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study. Osteoporos Int. 2019 Sep; 30(9):1755-1765.